Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review

Ward, 2014, Childhood and adolescent cancer statistics, 2014, CA. Canc. J. Clin., 64, 83, 10.3322/caac.21219 Bhakta, 2017, The cumulative burden of surviving childhood cancer: an initial report from the st jude lifetime cohort study (sjlife), Lancet(LDN. ENGL.), 390, 2569 Phillips, 2015, Survivors of childhood cancer in the United States: prevalence and burden of morbidity, Canc. Epidemiol. Biomarker. Prev, 24, 653, 10.1158/1055-9965.EPI-14-1418 Mulrooney, 2019, The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the st jude lifetime cohort study, Lance. Haematol., 6, e306, 10.1016/S2352-3026(19)30050-X Gilchrist, 2017, Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-cns cancer, Pediatr. Blood Canc., 64, 180, 10.1002/pbc.26204 Bjornard, 2018, Peripheral neuropathy in children and adolescents treated for cancer, Lance. Chil. Adolesc. Heal, 2, 744, 10.1016/S2352-4642(18)30236-0 Loprinzi, 2020, Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: asco guideline update, J. Clin. Oncol., 38, 10.1200/JCO.20.01399 Jordan, 2020, Systemic anticancer therapy-induced peripheral and central neurotoxicity: esmo–eons–eano clinical practice guidelines for diagnosis, prevention, treatment and follow-up, Ann. Oncol., 31, 1306, 10.1016/j.annonc.2020.07.003 Smith, 2013, Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy, JAMA., 309, 1359, 10.1001/jama.2013.2813 Kandula, 2016, Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge, Canc. Treat Rev., 50, 118, 10.1016/j.ctrv.2016.09.005 Sun, 2018, Neurological complications of the treatment of pediatric neoplastic disorders, Pediatr. Neurol., 85, 33, 10.1016/j.pediatrneurol.2018.05.011 van de Velde, 2017, Vincristine-induced peripheral neuropathy in children with cancer: a systematic review, Crit. Rev. Oncol. Hematol., 114, 114, 10.1016/j.critrevonc.2017.04.004 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the prisma statement, PLoS. Med., 6, 10.1371/journal.pmed.1000097 Munn, 2015, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data, JBI. Evid. Implem., 13, 147 Institute T.J.B. Joanna Briggs Institute Critical Appraisal Tools. 2017. http://joannabriggs-webdev.org/research/critical-appraisal-tools.html (accessed May 7, 2020). Bradfield, 2015, Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer, Pediatr. Blood Canc., 62, 1004, 10.1002/pbc.25384 Moreno, 2018, Phase I results of a phase i/ii study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: a collaboration with innovative therapies for children with cancer, Eur. J. Canc., 100, 27, 10.1016/j.ejca.2018.05.002 Iguchi, 2017, Bortezomib combined with standard induction chemotherapy in japanese children with refractory acute lymphoblastic leukemia, Int. J. Hematol., 106, 291, 10.1007/s12185-017-2235-z Mokhtar, 2010, A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study, J. Pediatr. Hematol. Oncol., 32, 594, 10.1097/MPH.0b013e3181e9038d Kayilioğlu, 2017, Association of cyp3a5 expression and vincristine neurotoxicity in pediatric malignancies in turkish population, J. Pediatr. Hematol. Oncol., 39, 458, 10.1097/MPH.0000000000000910 Sims, 2016, The effect of race on the cyp3a-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia, J. Oncol. Pharm. Pract., 22, 76, 10.1177/1078155214553143 Ibrahim, 2013, Electrophysiological study of peripheral nerves in children with acute lymphoblastic leukemia, Egypt Rheumatol. Rehabil., 40, 63, 10.7123/01.ERR.0000426384.78772.59 Nama, 2020, Vincristine-induced peripheral neurotoxicity: a prospective cohort, Pediatr. Hematol. Oncol., 37, 15, 10.1080/08880018.2019.1677832 Gilchrist, 2018, Short-term recovery of balance control: association with chemotherapy-induced peripheral neuropathy in pediatric oncology, Pediatr. Phys. Ther., 30, 119, 10.1097/PEP.0000000000000484 Wahba, 2013, Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study, J. BUON., 18, 425 Rosca, 2018, Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas, Pediatr. Blood Canc., 65, e27351, 10.1002/pbc.27351 Purser, 2014, Chemotherapy-induced peripheral neuropathy among paediatric oncology patients, Can. J. Neurol. Sci., 41, 442, 10.1017/S0317167100018461 Nazir, 2017, Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in oman: frequent autonomic and more severe cranial nerve involvement, Pediatr. Blood Canc., 64, e26677, 10.1002/pbc.26677 Moore, 2011, Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach, J. Paediatr. Child Heal., 47, 875, 10.1111/j.1440-1754.2011.02103.x Egbelakin, 2011, Increased risk of vincristine neurotoxicity associated with low cyp3a5 expression genotype in children with acute lymphoblastic leukemia, Pediatr. Blood Canc., 56, 361, 10.1002/pbc.22845 Lavoie Smith, 2015, Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia, J. Peripher. Nerv. Syst., 20, 37, 10.1111/jns.12114 Smith, 2013, Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia, Canc. Nurs., 36, E49, 10.1097/NCC.0b013e318299ad23 Skiles, 2018, CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in kenyan children with cancer, Pediatr. Blood Canc., 65, 1, 10.1002/pbc.26854 Zgheib, 2018, Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in arab children treated for acute childhood leukemia: a single institution study, Pharmacogenet. Genomi., 28, 189, 10.1097/FPC.0000000000000345 Anghelescu, 2011, Neuropathic pain during treatment for childhood acute lymphoblastic leukemia, Pediatr. Blood Canc., 57, 1147, 10.1002/pbc.23039 Lombardi, 2015, Vincristine-associated neurological morbidity in the treatment of hepatoblastoma, J. Pediatr. Hematol. Oncol., 37, e258, 10.1097/MPH.0000000000000321 Dudeja, 2019, Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies, Pediatr. Hematol. Oncol., 36, 344, 10.1080/08880018.2019.1637981 Diouf, 2015, Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia, JAMA., 313, 815, 10.1001/jama.2015.0894 Millan, 2018, Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia, Leuk. Res., 65, 86, 10.1016/j.leukres.2017.12.010 Gilchrist, 2014, Chemotherapy-induced peripheral neuropathy in non-cns cancers: comparison between diagnostic groups, Pediatr. Blood Canc., 61, S393 Brigo, 2012, Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia, J. Child Neurol., 27, 867, 10.1177/0883073811428379 Courtemanche, 2015, Vincristine-induced neuropathy: atypical electrophysiological patterns in children, Muscl. Nerv., 52, 981, 10.1002/mus.24647 Kandula, 2018, Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes, JAMA. Neurol., 75, 980, 10.1001/jamaneurol.2018.0963 Vivas-Rosales, 2017, Chemotherapy-induced peripheral neuropathy in a subpopulation of mexican pediatric patients with acute lymphoblastic leukemia, Iran. J. Pediatr., 27, e11844, 10.5812/ijp.11844 Jain, 2014, Vincristine-induced neuropathy in childhood all (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics, J. Child Neurol., 29, 932, 10.1177/0883073813491829 Sabarre, 2014, Vincristine and fine motor function of children with acute lymphoblastic leukemia, Can. J. Occup. Ther., 81, 256, 10.1177/0008417414539926 Wright, 2019, Multidimensional outcome measurement of children and youth with neuropathy following treatment of leukemia: cross-sectional descriptive report, Rehabil. Oncol., 37, 160, 10.1097/01.REO.0000000000000152 Yildiz, 2016, Vincristine-induced neurotoxicity: electrophysiological features in children, Neurol. Res., 38, 124, 10.1080/01616412.2016.1139321 Tay, 2017, Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia, Pediatr. Blood Canc., 64, e26471, 10.1002/pbc.26471 Lieber, 2018, Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia, Eur. J. Paediatr. Neurol., 22, 457, 10.1016/j.ejpn.2017.12.019 Wright, 2017, Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia, Gait. Postu., 58, 139, 10.1016/j.gaitpost.2017.05.004 Gomber, 2010, Vincristine induced neurotoxicity in cancer patients, Ind. J. Pediatr., 77, 97, 10.1007/s12098-009-0254-3 Schouten, 2020, Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the dutch pediatric–modified total neuropathy score, Suppo. Care Canc., 28, 2867, 10.1007/s00520-019-05106-3 Ness, 2015, Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia, Blood., 125, 3411, 10.1182/blood-2015-01-621680 Gilchrist, 2013, The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-cns cancers, Suppo. Care Canc., 21, 847, 10.1007/s00520-012-1591-8 Gilchrist, 2014, Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children, Suppo. Care Canc., 22, 359, 10.1007/s00520-013-1981-6 Millan, 2018, Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia, Leuk. Res., 65, 86, 10.1016/j.leukres.2017.12.010 ajdyk, 2020, Obesity as a potential risk factor for vincristine-induced peripheral neuropathy, J. Pediatr. Hematol. Oncol., 42, e637, 10.1097/MPH.0000000000001604 Griffiths, 2018, Psychometric properties of gross motor assessment tools for children: a systematic review, BMJ. Open., 8, 10.1136/bmjopen-2018-021734 Schwartz, 2008, The gait deviation index: a new comprehensive index of gait pathology, Gait Postu., 28, 351, 10.1016/j.gaitpost.2008.05.001 Podsiadlo, 1991, The timed ‘up & go’: a test of basic functional mobility for frail elderly persons, J. Am. Geriatr. Soc., 39, 142, 10.1111/j.1532-5415.1991.tb01616.x Ghanem, 2018, Genetic polymorphisms in candidate genes including cep72 are not associated with increased vincristine-related peripheral neuropathy in arab children treated for acute childhood leukemia, Pediatr. Blood Canc., 65, S117 Chaudhry, 1996, A prospective study of suramin-induced peripheral neuropathy, Brain, 119, 2039, 10.1093/brain/119.6.2039 Smith, 2020, Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review, Lancet Haematol., 7, e408, 10.1016/S2352-3026(20)30064-8 Smith, 2008, The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy, Oncol. Nurs. For., 35, 96 Gilchrist, 2009, Measuring chemotherapy-induced peripheral neuropathy in children: development of the ped-mtns and pilot study results, Rehabil. Oncol., 27, 7, 10.1097/01893697-200927030-00002 Lieber, 2016, Quantitative sensory testing is highly sensitive in detecting chemotherapy-induced peripheral neuropathy, Neuropediatr., 47, FV01, 10.1055/s-0036-1583708 Hjermstad, 1998, Health-related quality of life in the general norwegian population assessed by the european organization for research and treatment of cancer core quality-of-life questionnaire: the qlq=c30 (+ 3), J. Clin. Oncol., 16, 1188, 10.1200/JCO.1998.16.3.1188 Marais, 2012, Comparison of 2 measures of chemotherapyinduced peripheral neuropathy in schoolaged children undergoing neurotoxic cancer treatment, Rehabil. Oncol., 30, 26, 10.1097/01893697-201230010-00013 Skiles, 2016, The absence of vincristine neuropathy in Kenyan children with cancer: the good, the bad, and the (possibly) ugly, Pediatr. Blood Canc., 63, S148 Van De Velde, 2019, Vincristine-induced peripheral neuropathy in pediatric oncology patients receiving vincristine through push injections or one-hour infusions: results of a randomized clinical trial, Blood ., 134, 1350, 10.1182/blood-2019-126532 Ness, 2013, Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the st. jude lifetime cohort study, Arch. Phys. Med. Rehabil., 94, 1451, 10.1016/j.apmr.2013.03.009 Frigeni, 2011, Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the national cancer institute common toxicity scale, J. Peripher. Nerv. Syst., 16, 228, 10.1111/j.1529-8027.2011.00351.x Park, 2019, Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity, J. Peripher. Nerv. Syst., 24, 13, 10.1111/jns.12333 Basch, 2014, The rationale for collecting patient-reported symptoms during routine chemotherapy, Am. Soc. Clin. Oncol. Educ. B., 34, 161, 10.14694/EdBook_AM.2014.34.161 Alberti, 2014, Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin, Ann. Oncol., 25, 257, 10.1093/annonc/mdt409 Lavoie Smith, 2011, The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums, Oncol. Nurs. For., 38, 133 Cavaletti, 2010, Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools, Eur. J. Canc., 46, 479, 10.1016/j.ejca.2009.12.008 Postma, 1998, Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy, Ann. Oncol., 9, 739, 10.1023/A:1008344507482